MedTrace Logo

High Intensity Interval Training and Technologies in COPD

NCT05343949 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-04-11

No results posted yet for this study

Summary

Trials in COPD have shown that HIIT leads to the same positive outcomes as constant load training but causes less breathlessness and leg discomfort during training. However, HIIT protocols in existing trials have all been different and use relatively long interval durations (30 s) and short rests. This is sub-optimal because long interval durations lead to greater breathlessness and patients may fear that they will not fully recover during short rests, potentially decreasing adherence. A novel HIIT protocol involving very brief intervals (e.g. 10 s) with longer rests may provide the same benefits with less distress due to breathlessness.

Conditions

Interventions

OTHER

HIIT exercise program ABC

Delivery of 3 different exercise programs to patients with COPD to determine which program gives least breathlessness with the same exercise benefits

OTHER

HIIT exercise program CAB

Delivery of 3 different exercise programs to patients with COPD to determine which program gives least breathlessness with the same exercise benefits

OTHER

HIIT exercise program BCA

Delivery of 3 different exercise programs to patients with COPD to determine which program gives least breathlessness with the same exercise benefits

Sponsors & Collaborators

  • Hull University Teaching Hospitals NHS Trust

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-08
Primary Completion
2022-11-25
Completion
2022-11-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05343949 on ClinicalTrials.gov